Abnormal EPB41L4A-AS1 expression was prominently associated with TNM stage (P = 0.024) and lymph node metastasis (P = 0.035) in gastric cancer patients. Here, EPB41L4A is linked to metastatic malignant neoplasm in the lymph nodes.